Thomas J. Schuetz, CHIEF EXECUTIVE OFFICER at Compass Therapeutics, Inc. (CMPX), bought 40,000 shares at $3.03 ($121K) on 2022-06-01, disclosed to the SEC on 2022-06-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.03 | 20,000 | $61K | 50.0% |
| 2 | $3.03 | 20,000 | $61K | 50.0% |
| Total | $3.03 avg | 40,000 | $121K | 100% |
| Filing → |
| CMPX | BUY | 2023-02-27 | $80K | — | Filing → |
| CMPX | BUY | 2023-02-15 | $77K | — | Filing → |
| CMPX | BUY | 2023-01-31 | $81K | — | Filing → |